On July 30, 2012 the Board of Directors of Human Stem Cells Institute Open Joint-Stock Company elected Aleksandr Prikhodko as Chairman of the Board.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59.54 RUB | +1.43% | -.--% | -.--% |
04-26 | Artgen Biotech PJSC Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Artgen Biotech PJSC Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 50.36M | |
+23.37% | 86.96B | |
-24.25% | 75.65B | |
+0.49% | 26.97B | |
+5.56% | 17.89B | |
-12.99% | 16.58B | |
+2.69% | 15.73B | |
+74.36% | 13.01B | |
+77.46% | 12.92B | |
+36.37% | 12.57B |
- Stock Market
- Equities
- ISKJ Stock
- News Human Stem Cells Institute
- Human Stem Cells Institute Open Joint-Stock Company Elects Aleksandr Prikhodko as Chairman of the Board